APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vascular Endothelial Growth Factor B

Compare research editions
View pricing & licenses

Selected research

Industry Research

Vascular Endothelial Growth Factor B Industry Research Report 2026

22 December 2025115 pages

Choose your research edition.

Industry ResearchVascular Endothelial Growth Factor B Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Vascular Endothelial Growth Factor B Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Vascular Endothelial Growth Factor B Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vascular Endothelial Growth Factor B Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Vascular Endothelial Growth Factor B Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Vascular Endothelial Growth Factor B market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Vascular Endothelial Growth Factor B is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Vascular Endothelial Growth Factor B is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Vascular Endothelial Growth Factor B is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Vascular Endothelial Growth Factor B include Eli Lilly and Company, Regeneron Pharmaceuticals Inc, Formycon AG, CSL Ltd and Alteogen Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Vascular Endothelial Growth Factor B market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Vascular Endothelial Growth Factor B Market by Company

Eli Lilly and Company

Regeneron Pharmaceuticals Inc

Formycon AG

CSL Ltd

Alteogen Inc

Vascular Endothelial Growth Factor B Segment by Type

CSL-346

Aflibercept

Aflibercept Biosimilar

Others

Vascular Endothelial Growth Factor B Segment by Application

Rectal Cancer

Diabetic Nephropathy

Retinal Vein Occlusion

Others

Vascular Endothelial Growth Factor B Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vascular Endothelial Growth Factor B market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vascular Endothelial Growth Factor B and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vascular Endothelial Growth Factor B.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Vascular Endothelial Growth Factor B manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Vascular Endothelial Growth Factor B by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Vascular Endothelial Growth Factor B in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Vascular Endothelial Growth Factor B Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Vascular Endothelial Growth Factor B Sales (k units) of Manufacturers (2021-2026) Table 7. Global Vascular Endothelial Growth Factor B Sales Market Share by Manufacturers (2021-2026) Table 8. Global Vascular Endothelial Growth Factor B Revenue of Manufacturers (2021-2026) Table 9. Global Vascular Endothelial Growth Factor B Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Vascular Endothelial Growth Factor B Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Vascular Endothelial Growth Factor B Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Vascular Endothelial Growth Factor B, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Vascular Endothelial Growth Factor B, Product Type & Application Table 14. Global Vascular Endothelial Growth Factor B Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Vascular Endothelial Growth Factor B by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Eli Lilly and Company Company Information Table 19. Eli Lilly and Company Business Overview Table 20. Eli Lilly and Company Vascular Endothelial Growth Factor B Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Eli Lilly and Company Vascular Endothelial Growth Factor B Product Portfolio Table 22. Eli Lilly and Company Recent Developments Table 23. Regeneron Pharmaceuticals Inc Company Information Table 24. Regeneron Pharmaceuticals Inc Business Overview Table 25. Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Product Portfolio Table 27. Regeneron Pharmaceuticals Inc Recent Developments Table 28. Formycon AG Company Information Table 29. Formycon AG Business Overview Table 30. Formycon AG Vascular Endothelial Growth Factor B Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Formycon AG Vascular Endothelial Growth Factor B Product Portfolio Table 32. Formycon AG Recent Developments Table 33. CSL Ltd Company Information Table 34. CSL Ltd Business Overview Table 35. CSL Ltd Vascular Endothelial Growth Factor B Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. CSL Ltd Vascular Endothelial Growth Factor B Product Portfolio Table 37. CSL Ltd Recent Developments Table 38. Alteogen Inc Company Information Table 39. Alteogen Inc Business Overview Table 40. Alteogen Inc Vascular Endothelial Growth Factor B Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Alteogen Inc Vascular Endothelial Growth Factor B Product Portfolio Table 42. Alteogen Inc Recent Developments Table 43. Global Vascular Endothelial Growth Factor B Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Vascular Endothelial Growth Factor B Sales by Region (2021-2026) & (k units) Table 45. Global Vascular Endothelial Growth Factor B Sales Market Share by Region (2021-2026) Table 46. Global Vascular Endothelial Growth Factor B Sales by Region (2027-2032) & (k units) Table 47. Global Vascular Endothelial Growth Factor B Sales Market Share by Region (2027-2032) Table 48. Global Vascular Endothelial Growth Factor B Revenue by Region (2021-2026) & (US$ Million) Table 49. Global Vascular Endothelial Growth Factor B Revenue Market Share by Region (2021-2026) Table 50. Global Vascular Endothelial Growth Factor B Revenue by Region (2027-2032) & (US$ Million) Table 51. Global Vascular Endothelial Growth Factor B Revenue Market Share by Region (2027-2032) Table 52. North America Vascular Endothelial Growth Factor B Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 53. North America Vascular Endothelial Growth Factor B Sales by Country (2021-2026) & (k units) Table 54. North America Vascular Endothelial Growth Factor B Sales by Country (2027-2032) & (k units) Table 55. North America Vascular Endothelial Growth Factor B Revenue by Country (2021-2026) & (US$ Million) Table 56. North America Vascular Endothelial Growth Factor B Revenue by Country (2027-2032) & (US$ Million) Table 57. Europe Vascular Endothelial Growth Factor B Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Europe Vascular Endothelial Growth Factor B Sales by Country (2021-2026) & (k units) Table 59. Europe Vascular Endothelial Growth Factor B Sales by Country (2027-2032) & (k units) Table 60. Europe Vascular Endothelial Growth Factor B Revenue by Country (2021-2026) & (US$ Million) Table 61. Europe Vascular Endothelial Growth Factor B Revenue by Country (2027-2032) & (US$ Million) Table 62. Asia Pacific Vascular Endothelial Growth Factor B Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Asia Pacific Vascular Endothelial Growth Factor B Sales by Country (2021-2026) & (k units) Table 64. Asia Pacific Vascular Endothelial Growth Factor B Sales by Country (2027-2032) & (k units) Table 65. Asia Pacific Vascular Endothelial Growth Factor B Revenue by Country (2021-2026) & (US$ Million) Table 66. Asia Pacific Vascular Endothelial Growth Factor B Revenue by Country (2027-2032) & (US$ Million) Table 67. South America Vascular Endothelial Growth Factor B Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 68. South America Vascular Endothelial Growth Factor B Sales by Country (2021-2026) & (k units) Table 69. South America Vascular Endothelial Growth Factor B Sales by Country (2027-2032) & (k units) Table 70. South America Vascular Endothelial Growth Factor B Revenue by Country (2021-2026) & (US$ Million) Table 71. South America Vascular Endothelial Growth Factor B Revenue by Country (2027-2032) & (US$ Million) Table 72. Middle East and Africa Vascular Endothelial Growth Factor B Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 73. Middle East and Africa Vascular Endothelial Growth Factor B Sales by Country (2021-2026) & (k units) Table 74. Middle East and Africa Vascular Endothelial Growth Factor B Sales by Country (2027-2032) & (k units) Table 75. Middle East and Africa Vascular Endothelial Growth Factor B Revenue by Country (2021-2026) & (US$ Million) Table 76. Middle East and Africa Vascular Endothelial Growth Factor B Revenue by Country (2027-2032) & (US$ Million) Table 77. Global Vascular Endothelial Growth Factor B Sales by Type (2021-2026) & (k units) Table 78. Global Vascular Endothelial Growth Factor B Sales by Type (2027-2032) & (k units) Table 79. Global Vascular Endothelial Growth Factor B Sales Market Share by Type (2021-2026) Table 80. Global Vascular Endothelial Growth Factor B Sales Market Share by Type (2027-2032) Table 81. Global Vascular Endothelial Growth Factor B Revenue by Type (2021-2026) & (US$ Million) Table 82. Global Vascular Endothelial Growth Factor B Revenue by Type (2027-2032) & (US$ Million) Table 83. Global Vascular Endothelial Growth Factor B Revenue Market Share by Type (2021-2026) Table 84. Global Vascular Endothelial Growth Factor B Revenue Market Share by Type (2027-2032) Table 85. Global Vascular Endothelial Growth Factor B Price by Type (2021-2026) & (US$/unit) Table 86. Global Vascular Endothelial Growth Factor B Price by Type (2027-2032) & (US$/unit) Table 87. Global Vascular Endothelial Growth Factor B Sales by Application (2021-2026) & (k units) Table 88. Global Vascular Endothelial Growth Factor B Sales by Application (2027-2032) & (k units) Table 89. Global Vascular Endothelial Growth Factor B Sales Market Share by Application (2021-2026) Table 90. Global Vascular Endothelial Growth Factor B Sales Market Share by Application (2027-2032) Table 91. Global Vascular Endothelial Growth Factor B Revenue by Application (2021-2026) & (US$ Million) Table 92. Global Vascular Endothelial Growth Factor B Revenue by Application (2027-2032) & (US$ Million) Table 93. Global Vascular Endothelial Growth Factor B Revenue Market Share by Application (2021-2026) Table 94. Global Vascular Endothelial Growth Factor B Revenue Market Share by Application (2027-2032) Table 95. Global Vascular Endothelial Growth Factor B Price by Application (2021-2026) & (US$/unit) Table 96. Global Vascular Endothelial Growth Factor B Price by Application (2027-2032) & (US$/unit) Table 97. Key Raw Materials Table 98. Raw Materials Key Suppliers Table 99. Vascular Endothelial Growth Factor B Distributors List Table 100. Vascular Endothelial Growth Factor B Customers List Table 101. Vascular Endothelial Growth Factor B Industry Trends Table 102. Vascular Endothelial Growth Factor B Industry Drivers Table 103. Vascular Endothelial Growth Factor B Industry Restraints Table 104. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Vascular Endothelial Growth Factor B Product Image Figure 5. Global Vascular Endothelial Growth Factor B Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Vascular Endothelial Growth Factor B Market Size (2021-2032) & (US$ Million) Figure 7. Global Vascular Endothelial Growth Factor B Sales (2021-2032) & (k units) Figure 8. Global Vascular Endothelial Growth Factor B Average Price (US$/unit) & (2021-2032) Figure 9. CSL-346 Product Image Figure 10. Aflibercept Product Image Figure 11. Aflibercept Biosimilar Product Image Figure 12. Others Product Image Figure 13. Rectal Cancer Product Image Figure 14. Diabetic Nephropathy Product Image Figure 15. Retinal Vein Occlusion Product Image Figure 16. Others Product Image Figure 17. Global Vascular Endothelial Growth Factor B Revenue Share by Manufacturers in 2025 Figure 18. Global Manufacturers of Vascular Endothelial Growth Factor B, Manufacturing Sites & Headquarters Figure 19. Global Top 5 and 10 Vascular Endothelial Growth Factor B Players Market Share by Revenue in 2025 Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Vascular Endothelial Growth Factor B Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 22. Global Vascular Endothelial Growth Factor B Sales by Region in 2025 Figure 23. Global Vascular Endothelial Growth Factor B Revenue by Region in 2025 Figure 24. North America Vascular Endothelial Growth Factor B Market Size by Country in 2025 Figure 25. North America Vascular Endothelial Growth Factor B Sales Market Share by Country (2021-2032) Figure 26. North America Vascular Endothelial Growth Factor B Revenue Market Share by Country (2021-2032) Figure 27. United States Vascular Endothelial Growth Factor B Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Canada Vascular Endothelial Growth Factor B Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Mexico Vascular Endothelial Growth Factor B Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Europe Vascular Endothelial Growth Factor B Market Size by Country in 2025 Figure 31. Europe Vascular Endothelial Growth Factor B Sales Market Share by Country (2021-2032) Figure 32. Europe Vascular Endothelial Growth Factor B Revenue Market Share by Country (2021-2032) Figure 33. Germany Vascular Endothelial Growth Factor B Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. France Vascular Endothelial Growth Factor B Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. U.K. Vascular Endothelial Growth Factor B Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Italy Vascular Endothelial Growth Factor B Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Russia Vascular Endothelial Growth Factor B Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Spain Vascular Endothelial Growth Factor B Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Netherlands Vascular Endothelial Growth Factor B Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Switzerland Vascular Endothelial Growth Factor B Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Sweden Vascular Endothelial Growth Factor B Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Poland Vascular Endothelial Growth Factor B Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Asia Pacific Vascular Endothelial Growth Factor B Market Size by Country in 2025 Figure 44. Asia Pacific Vascular Endothelial Growth Factor B Sales Market Share by Country (2021-2032) Figure 45. Asia Pacific Vascular Endothelial Growth Factor B Revenue Market Share by Country (2021-2032) Figure 46. China Vascular Endothelial Growth Factor B Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Japan Vascular Endothelial Growth Factor B Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. South Korea Vascular Endothelial Growth Factor B Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. India Vascular Endothelial Growth Factor B Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Australia Vascular Endothelial Growth Factor B Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Taiwan Vascular Endothelial Growth Factor B Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Vascular Endothelial Growth Factor B Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Southeast Asia Vascular Endothelial Growth Factor B Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. South America Vascular Endothelial Growth Factor B Market Size by Country in 2025 Figure 55. South America Vascular Endothelial Growth Factor B Sales Market Share by Country (2021-2032) Figure 56. South America Vascular Endothelial Growth Factor B Revenue Market Share by Country (2021-2032) Figure 57. Brazil Vascular Endothelial Growth Factor B Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Argentina Vascular Endothelial Growth Factor B Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Chile Vascular Endothelial Growth Factor B Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Middle East and Africa Vascular Endothelial Growth Factor B Market Size by Country in 2025 Figure 61. Middle East and Africa Vascular Endothelial Growth Factor B Sales Market Share by Country (2021-2032) Figure 62. Middle East and Africa Vascular Endothelial Growth Factor B Revenue Market Share by Country (2021-2032) Figure 63. Egypt Vascular Endothelial Growth Factor B Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. South Africa Vascular Endothelial Growth Factor B Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Israel Vascular Endothelial Growth Factor B Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Türkiye Vascular Endothelial Growth Factor B Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. GCC Countries Vascular Endothelial Growth Factor B Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Global Vascular Endothelial Growth Factor B Sales Market Share by Type (2021-2032) Figure 69. Global Vascular Endothelial Growth Factor B Revenue Market Share by Type (2021-2032) Figure 70. Global Vascular Endothelial Growth Factor B Price (US$/unit) by Type (2021-2032) Figure 71. Global Vascular Endothelial Growth Factor B Sales Market Share by Application (2021-2032) Figure 72. Global Vascular Endothelial Growth Factor B Revenue Market Share by Application (2021-2032) Figure 73. Global Vascular Endothelial Growth Factor B Price (US$/unit) by Application (2021-2032) Figure 74. Vascular Endothelial Growth Factor B Value Chain Figure 75. Vascular Endothelial Growth Factor B Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Vascular Endothelial Growth Factor B Industry Opportunities and Challenges

Scope & coverage.

Types
  • CSL-346
  • Aflibercept
  • Aflibercept Biosimilar
  • Others
Applications
  • Rectal Cancer
  • Diabetic Nephropathy
  • Retinal Vein Occlusion
  • Others
Companies covered
  • Eli Lilly and Company
  • Regeneron Pharmaceuticals Inc
  • Formycon AG
  • CSL Ltd
  • Alteogen Inc

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Vascular Endothelial Growth Factor B Market Size (2021-2032)
  4. 2.2.2 Global Vascular Endothelial Growth Factor B Sales (2021-2032)
  5. 2.2.3 Global Vascular Endothelial Growth Factor B Market Average Price (2021-2032)
  6. 2.3 Vascular Endothelial Growth Factor B by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 CSL-346
  9. 2.3.3 Aflibercept
  10. 2.3.4 Aflibercept Biosimilar
  11. 2.3.5 Others
  12. 2.4 Vascular Endothelial Growth Factor B by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Rectal Cancer
  15. 2.4.3 Diabetic Nephropathy
  16. 2.4.4 Retinal Vein Occlusion
  17. 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Vascular Endothelial Growth Factor B Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Vascular Endothelial Growth Factor B Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Vascular Endothelial Growth Factor B Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Vascular Endothelial Growth Factor B Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Vascular Endothelial Growth Factor B Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Vascular Endothelial Growth Factor B, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Vascular Endothelial Growth Factor B, Product Type & Application
  8. 3.8 Global Manufacturers of Vascular Endothelial Growth Factor B, Established Date
  9. 3.9 Global Vascular Endothelial Growth Factor B Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Eli Lilly and Company
  2. 4.1.1 Eli Lilly and Company Company Information
  3. 4.1.2 Eli Lilly and Company Business Overview
  4. 4.1.3 Eli Lilly and Company Vascular Endothelial Growth Factor B Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Eli Lilly and Company Vascular Endothelial Growth Factor B Product Portfolio
  6. 4.1.5 Eli Lilly and Company Recent Developments
  7. 4.2 Regeneron Pharmaceuticals Inc
  8. 4.2.1 Regeneron Pharmaceuticals Inc Company Information
  9. 4.2.2 Regeneron Pharmaceuticals Inc Business Overview
  10. 4.2.3 Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Product Portfolio
  12. 4.2.5 Regeneron Pharmaceuticals Inc Recent Developments
  13. 4.3 Formycon AG
  14. 4.3.1 Formycon AG Company Information
  15. 4.3.2 Formycon AG Business Overview
  16. 4.3.3 Formycon AG Vascular Endothelial Growth Factor B Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Formycon AG Vascular Endothelial Growth Factor B Product Portfolio
  18. 4.3.5 Formycon AG Recent Developments
  19. 4.4 CSL Ltd
  20. 4.4.1 CSL Ltd Company Information
  21. 4.4.2 CSL Ltd Business Overview
  22. 4.4.3 CSL Ltd Vascular Endothelial Growth Factor B Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 CSL Ltd Vascular Endothelial Growth Factor B Product Portfolio
  24. 4.4.5 CSL Ltd Recent Developments
  25. 4.5 Alteogen Inc
  26. 4.5.1 Alteogen Inc Company Information
  27. 4.5.2 Alteogen Inc Business Overview
  28. 4.5.3 Alteogen Inc Vascular Endothelial Growth Factor B Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Alteogen Inc Vascular Endothelial Growth Factor B Product Portfolio
  30. 4.5.5 Alteogen Inc Recent Developments
5 Global Vascular Endothelial Growth Factor B Market Scenario by Region
  1. 5.1 Global Vascular Endothelial Growth Factor B Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Vascular Endothelial Growth Factor B Sales by Region: 2021-2032
  3. 5.2.1 Global Vascular Endothelial Growth Factor B Sales by Region: 2021-2026
  4. 5.2.2 Global Vascular Endothelial Growth Factor B Sales by Region: 2027-2032
  5. 5.3 Global Vascular Endothelial Growth Factor B Revenue by Region: 2021-2032
  6. 5.3.1 Global Vascular Endothelial Growth Factor B Revenue by Region: 2021-2026
  7. 5.3.2 Global Vascular Endothelial Growth Factor B Revenue by Region: 2027-2032
  8. 5.4 North America Vascular Endothelial Growth Factor B Market Facts & Figures by Country
  9. 5.4.1 North America Vascular Endothelial Growth Factor B Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Vascular Endothelial Growth Factor B Sales by Country (2021-2032)
  11. 5.4.3 North America Vascular Endothelial Growth Factor B Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Vascular Endothelial Growth Factor B Market Facts & Figures by Country
  16. 5.5.1 Europe Vascular Endothelial Growth Factor B Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Vascular Endothelial Growth Factor B Sales by Country (2021-2032)
  18. 5.5.3 Europe Vascular Endothelial Growth Factor B Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Vascular Endothelial Growth Factor B Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Vascular Endothelial Growth Factor B Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Vascular Endothelial Growth Factor B Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Vascular Endothelial Growth Factor B Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Vascular Endothelial Growth Factor B Market Facts & Figures by Country
  41. 5.7.1 South America Vascular Endothelial Growth Factor B Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Vascular Endothelial Growth Factor B Sales by Country (2021-2032)
  43. 5.7.3 South America Vascular Endothelial Growth Factor B Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Vascular Endothelial Growth Factor B Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Vascular Endothelial Growth Factor B Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Vascular Endothelial Growth Factor B Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Vascular Endothelial Growth Factor B Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Vascular Endothelial Growth Factor B Sales by Type (2021-2032)
  2. 6.1.1 Global Vascular Endothelial Growth Factor B Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Vascular Endothelial Growth Factor B Sales Market Share by Type (2021-2032)
  4. 6.2 Global Vascular Endothelial Growth Factor B Revenue by Type (2021-2032)
  5. 6.2.1 Global Vascular Endothelial Growth Factor B Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Vascular Endothelial Growth Factor B Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Vascular Endothelial Growth Factor B Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Vascular Endothelial Growth Factor B Sales by Application (2021-2032)
  2. 7.1.1 Global Vascular Endothelial Growth Factor B Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Vascular Endothelial Growth Factor B Sales Market Share by Application (2021-2032)
  4. 7.2 Global Vascular Endothelial Growth Factor B Revenue by Application (2021-2032)
  5. 7.2.1 Global Vascular Endothelial Growth Factor B Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Vascular Endothelial Growth Factor B Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Vascular Endothelial Growth Factor B Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Vascular Endothelial Growth Factor B Value Chain Analysis
  2. 8.1.1 Vascular Endothelial Growth Factor B Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Vascular Endothelial Growth Factor B Production Mode & Process
  5. 8.2 Vascular Endothelial Growth Factor B Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Vascular Endothelial Growth Factor B Distributors
  8. 8.2.3 Vascular Endothelial Growth Factor B Customers
9 Global Vascular Endothelial Growth Factor B Analyzing Market Dynamics
  1. 9.1 Vascular Endothelial Growth Factor B Industry Trends
  2. 9.2 Vascular Endothelial Growth Factor B Industry Drivers
  3. 9.3 Vascular Endothelial Growth Factor B Industry Opportunities and Challenges
  4. 9.4 Vascular Endothelial Growth Factor B Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst